| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/07/2002 | CA2415433A1 A human disintegrin protein |
| 02/06/2002 | EP1178116A1 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 02/06/2002 | EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases |
| 02/06/2002 | EP1177313A2 Method for localising proteases which split substrates that are specifically connected by a membrane |
| 02/06/2002 | EP1177301A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 02/06/2002 | EP1177287A2 Secreted human proteins |
| 02/06/2002 | EP1177286A1 Mdm interacting protein and methods of use thereof |
| 02/06/2002 | EP1177285A1 Chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/06/2002 | EP1177215A1 Constitutive chimeric receptors, and methods of use thereof |
| 02/06/2002 | EP1064389A4 Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use |
| 02/05/2002 | US6344552 Compositions and methods comprising DNA sequences encoding B. burgdorferi polypeptides |
| 02/05/2002 | CA2089094C Expression of recombinant polypeptides with improved purification |
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008288A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | WO2002008287A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008284A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | WO2002008272A2 High affinity soluble interleukin-18 receptor |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008267A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | WO2002008263A2 Modified virus having an altered tropism |
| 01/31/2002 | WO2002008257A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 01/31/2002 | WO2002008253A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 01/31/2002 | WO2002008252A2 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | WO2001077321A3 Identification of a human gaba transporter |
| 01/31/2002 | WO2001062940A3 New phosphodiesterase type 7b |
| 01/31/2002 | WO2001061017A3 Modified cytokines for use in cancer therapy |
| 01/31/2002 | WO2001057065A3 Combinatorial protein domains |
| 01/31/2002 | US20020012992 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 01/31/2002 | US20020012965 Nucleotide sequences coding prfeerential polypeptides for use in the diagnosis and treatment of brain disorders and injury |
| 01/31/2002 | US20020012962 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia |
| 01/31/2002 | US20020012669 For detecting a genetic abnormality, cancer |
| 01/31/2002 | CA2797652A1 Multi-component biological transport systems |
| 01/31/2002 | CA2418282A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | CA2418215A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | CA2418198A1 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | CA2417223A1 A novel member of the epha receptor family |
| 01/31/2002 | CA2416733A1 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | CA2416713A1 Novel siglecs and uses thereof |
| 01/31/2002 | CA2416691A1 Proteases |
| 01/31/2002 | CA2416664A1 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | CA2416538A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | CA2416456A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | CA2413851A1 Modified virus having an altered tropism |
| 01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
| 01/30/2002 | EP1176201A2 Platelet-specific chimeric immunoglobulin |
| 01/30/2002 | EP1175498A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 01/30/2002 | EP1175436A2 Transiently immortalized cells for use in gene therapy |
| 01/30/2002 | CN1333832A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2002 | CN1333830A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 01/30/2002 | CN1333829A Polypeptide |
| 01/30/2002 | CN1333828A Compositions and methods for increasing bone mineralization |
| 01/30/2002 | CN1333819A Method for high level expression of active lymphotoxin-betareceptor immunoglobulin |
| 01/30/2002 | CN1333785A Interferon-beta fusion proteins and uses |
| 01/29/2002 | US6342224 For prophylaxis and therapy of human papilloma induced tumours |
| 01/29/2002 | US6342220 Agonist antibodies |
| 01/24/2002 | WO2002006463A2 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 01/24/2002 | WO2002006328A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/24/2002 | WO2002006317A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | WO2002006311A2 Olfactory g-protein coupled receptor |
| 01/24/2002 | WO2002006306A2 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 01/24/2002 | WO2002006305A1 Method of collecting viral envelope from germinating baculovirus |
| 01/24/2002 | WO2002005844A2 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | WO2001051515A3 Genes differentially expressed in breast cancer |
| 01/24/2002 | WO2001044286A3 Five-helix protein |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
| 01/24/2002 | WO2001025397A3 Compositions and methods for tumor-targeted delivery of effector molecules |
| 01/24/2002 | WO2000073453A9 T-bet compositions and methods of use thereof |
| 01/24/2002 | US20020010325 Complexing; purified polypeptide |
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009739 Metastatic breast and colon cancer regulated genes |
| 01/24/2002 | US20020009452 Method for altering undesirable immune responses to polypeptides |
| 01/24/2002 | CA2418391A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | CA2418207A1 Dendritic cell-derived nucleic acids and related compositions and methods |
| 01/24/2002 | CA2415726A1 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 01/24/2002 | CA2415712A1 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | CA2415687A1 Novel g-protein coupled receptor |
| 01/24/2002 | CA2410898A1 Substrates and assays for .beta.-secretase activity |
| 01/23/2002 | EP1174502A1 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/23/2002 | EP1173765A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 01/23/2002 | EP1173591A2 Pesticidal fusions |
| 01/23/2002 | EP1173589A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
| 01/23/2002 | EP1173569A1 Synthetic signalling molecules |
| 01/23/2002 | EP1173563A1 Compositions and methods for the treatment of tumour |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173486A1 Antibodies that recognize app cleaved by caspases and methods of use |
| 01/23/2002 | EP1173475A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 01/23/2002 | EP1173204A1 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/23/2002 | EP0700445B1 Stress proteins and uses therefor |
| 01/23/2002 | CN1332803A Streptococcus antigens |
| 01/23/2002 | CN1332802A Production of recombinant monellin using methylotrophic yeast expression system |
| 01/23/2002 | CN1332749A HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/22/2002 | CA1341334C Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
| 01/17/2002 | WO2002004646A1 Expression system |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |